Royal Bank of Canada
TERN

Royal Bank of Canada’s Terns Pharmaceuticals TERN Stock Holding History

Royal Bank of Canada’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.16M Buy
78,912
+75,842
+2,470% +$3.12M ﹤0.01% 2551
2025
Q4 		$123K Sell
3,070
-12,643
-80% -$292K ﹤0.01% 5090
2025
Q3 		$117K Sell
15,713
-178,632
-92% -$1.14M ﹤0.01% 5429
2025
Q2 		$725K Buy
194,345
+188,717
+3,353% +$589K ﹤0.01% 4184
2025
Q1 		$15K Sell
5,628
-4,334
-44% -$17.7K ﹤0.01% 6030
2024
Q4 		$55K Buy
9,962
+2,282
+30% +$15.5K ﹤0.01% 5645
2024
Q3 		$65K Sell
7,680
-181
-2% -$1.49K ﹤0.01% 5579
2024
Q2 		$54K Buy
7,861
+4,279
+119% +$25.9K ﹤0.01% 5617
2024
Q1 		$24K Sell
3,582
-10,860
-75% -$70.9K ﹤0.01% 5848
2023
Q4 		$93K Sell
14,442
-26,748
-65% -$141K ﹤0.01% 5662
2023
Q3 		$207K Sell
41,190
-43,789
-52% -$278K ﹤0.01% 4770
2023
Q2 		$744K Buy
84,979
+34,975
+70% +$408K ﹤0.01% 3626
2023
Q1 		$592K Buy
50,004
+49,822
+27,375% +$476K ﹤0.01% 3730
2022
Q4 		$2K Buy
+182
New +$1.21K ﹤0.01% 6946
2022
Q2 		– Sell
-843
Closed -$3K – 7706
2022
Q1 		$3K Sell
843
-2,231
-73% -$9.52K ﹤0.01% 7405
2021
Q4 		$22K Buy
3,074
+1,323
+76% +$11K ﹤0.01% 6767
2021
Q3 		$18K Buy
1,751
+1,155
+194% +$12K ﹤0.01% 6748
2021
Q2 		$7K Sell
596
-198
-25% -$3.37K ﹤0.01% 6989
2021
Q1 		$17K Buy
+794
New +$17.4K ﹤0.01% 6531

Other funds holding TERN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Royal Bank of Canada's TERN Position: Q1 2026 in Review

Royal Bank of Canada increased its Terns Pharmaceuticals (TERN) stake by 2,470% in Q1 2026, buying an estimated $3.12M and bringing the position to 78,912 shares worth $4.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2551.

Royal Bank of Canada first reported a position in TERN in Q1 2021 and has held it in 19 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Royal Bank of Canada held 78,912 shares of Terns Pharmaceuticals worth $4.16M as of Q1 2026.
  • Royal Bank of Canada bought 75,842 Terns Pharmaceuticals shares in Q1 2026, an estimated $3.12M.
  • Terns Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #2551 holding.
  • Royal Bank of Canada first reported a position in Terns Pharmaceuticals in Q1 2021 and has held it in 19 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.